StockWatch
·
Pharmaceuticals
Quarterly Result2 Nov 2026, 02:50 pm

Procter & Gamble Health declares Q2 FY27 Unaudited Financial Results

AI Summary

Procter & Gamble Health Ltd announced the approval of its Unaudited Financial Results for the quarter and half-year ended September 30, 2026. The Board of Directors convened today to review and approve these results, along with the Statement of Assets and Liabilities and Statement of Cash Flows. The company also submitted the Limited Review Report from its statutory auditors, Haribhakti & Co. LLP, confirming the adherence to accounting standards and regulations.

Key Highlights

  • Board approved Unaudited Financial Results for Q2 FY27.
  • Results cover the quarter and half-year ended September 30, 2026.
  • Statement of Assets and Liabilities and Cash Flows also approved.
  • Auditors' Limited Review Report submitted.
  • Results prepared as per Indian Accounting Standard 34.